Consistently, BrdU labeling analysis revealed that B-Myb overexpression enhanced DNA biosynthesis in CRC cells (Fig. 3e), whereas B-Myb knockdown reduced DNA biosynthesis (Fig. 3f). This evidence concerns the gene MYBL2 and colorectal carcinoma.